Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study.
Nebhan CA, Cortellini A, Ma W, Ganta T, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Ramaiya N, Presley CJ, Owen DH, Abou Alaiwi S, Nassar A, Ricciuti B, Lamberti G, Bersanelli M, Casartelli C, Buti S, Marchetti P, Giusti R, Filetti M, Vanella V, Mallardo D, Macherla S, Sussman TA, Botticelli A, Galetta D, Catino A, Pizzutilo P, Genova C, Dal Bello MG, Kalofonou F, Daniels E, Ascierto PA, Pinato DJ, Choueiri TK, Johnson DB, Marron TU, Wang Y, Naqash AR. Nebhan CA, et al. Among authors: dal bello mg. JAMA Oncol. 2021 Dec 1;7(12):1856-1861. doi: 10.1001/jamaoncol.2021.4960. JAMA Oncol. 2021. PMID: 34734989 Free PMC article.
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib.
Grossi F, Rijavec E, Dal Bello MG, Defferrari C, Brianti A, Barletta G, Genova C, Murolo C, Cosso M, Fontanini G, Boldrini L, Truini M, Pronzato P. Grossi F, et al. Among authors: dal bello mg. Cancer Chemother Pharmacol. 2012 Jun;69(6):1407-12. doi: 10.1007/s00280-012-1848-4. Epub 2012 Feb 21. Cancer Chemother Pharmacol. 2012. PMID: 22349923 Clinical Trial.
Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer.
Genova C, Rijavec E, Barletta G, Sini C, Dal Bello MG, Truini M, Murolo C, Pronzato P, Grossi F. Genova C, et al. Among authors: dal bello mg. Expert Opin Biol Ther. 2012 Jul;12(7):939-48. doi: 10.1517/14712598.2012.681371. Epub 2012 Apr 16. Expert Opin Biol Ther. 2012. PMID: 22506716 Review.
Pemetrexed for the treatment of non-small cell lung cancer.
Genova C, Rijavec E, Truini A, Coco S, Sini C, Barletta G, Dal Bello MG, Alama A, Savarino G, Pronzato P, Boccardo F, Grossi F. Genova C, et al. Among authors: dal bello mg. Expert Opin Pharmacother. 2013 Aug;14(11):1545-58. doi: 10.1517/14656566.2013.802774. Epub 2013 May 17. Expert Opin Pharmacother. 2013. PMID: 23683110 Review.
Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.
Rijavec E, Genova C, Alama A, Barletta G, Sini C, Pronzato P, Coco S, Dal Bello MG, Savarino G, Truini A, Boccardo F, Grossi F. Rijavec E, et al. Among authors: dal bello mg. Future Oncol. 2014 Jan;10(1):79-90. doi: 10.2217/fon.13.145. Future Oncol. 2014. PMID: 24328411 Review.
Afatinib for the treatment of advanced non-small-cell lung cancer.
Genova C, Rijavec E, Barletta G, Burrafato G, Biello F, Dal Bello MG, Coco S, Truini A, Alama A, Boccardo F, Grossi F. Genova C, et al. Among authors: dal bello mg. Expert Opin Pharmacother. 2014 Apr;15(6):889-903. doi: 10.1517/14656566.2014.902445. Expert Opin Pharmacother. 2014. PMID: 24646054 Review.
Oral vinorelbine in the treatment of non-small-cell lung cancer.
Barletta G, Genova C, Rijavec E, Burrafato G, Biello F, Sini C, Dal Bello MG, Coco S, Truini A, Vanni I, Alama A, Beltramini S, Grassi MA, Boccardo F, Grossi F. Barletta G, et al. Among authors: dal bello mg. Expert Opin Pharmacother. 2014 Aug;15(11):1585-99. doi: 10.1517/14656566.2014.934224. Epub 2014 Jun 27. Expert Opin Pharmacother. 2014. PMID: 24972635 Review.
Efficacy of motesanib diphosphate in non-small-cell lung cancer.
Rijavec E, Genova C, Barletta G, Biello F, Dal Bello MG, Coco S, Truini A, Vanni I, Alama A, Boccardo F, Grossi F. Rijavec E, et al. Among authors: dal bello mg. Expert Opin Pharmacother. 2014 Aug;15(12):1771-80. doi: 10.1517/14656566.2014.938639. Expert Opin Pharmacother. 2014. PMID: 25032887 Review.
69 results